Johnson & Johnson CEO to Apologize for Recalls
CEO William Weldon will apologize to Congress for a series of product recalls over the past year. The company is also expected to resume shipments of children's cold medication next week.
medical
Seattle Genetics Gets Positive Results From Lymphoma Treatment Tests
A proposed Hodgkin's lymphoma treatment returned positive test results in a clinical trial, according to drugmaker Seattle Genetics Inc., which seeks to file the drug for approval with the U.S. Food and Drug Administration next year.
U.S. Hospitals Get Better at Treating Heart Attacks, Pneumonia
U.S. hospitals are doing a more effective job treating patients for heart attacks, pneumonia and surgical procedures, an independent healthcare accreditation organization said in a report released today.
New Study: Obesity Is Bad for Your Bottom Line
Obesity is expensive. Each year, obese American men pay an additional $2,646 to carry their extra weight, while obese women pay $4,879. That's the surprising result of a new study on the individual cost of obesity.
The Next Marijuana Cartel: Pharmaceutical Companies?
A marijuana-based prescription drug for multiple sclerosis, Sativex, hit U.K. pharmacies Monday after winning regulator approval Friday. In light of the new approval, are arguments against medical marijuana half-baked?
Virtual Radiologic Deal: More Small-Cap Buyouts Ahead?
Virtual Radiologic provides remote diagnostic image interpretation, giving doctors anywhere fast answers about patients' medical scans. But vRad's growth hasn't been rapid enough to please the fickle market, which made it an attractive target for a private-equity buyout from Providence Equity Partners.
